TMCnet News
Arcutis to Host Virtual Investor Day on Wednesday, December 9, 2020WESTLAKE VILLAGE, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, will host a virtual Investor Day on Wednesday, Dec. 9, 2020, from 11:00 - 1:00 p.m. EST. The Company plans to showcase its unique immune-dermatology product development platform and robust pipeline of novel drug candidates targeting multiple dermatologic indications. Presentations will be given by Arcutis’ Senior Leadership Team in addition to Zoe Diana Draelos, M.D., consulting professor of dermatology, Duke University School of Medicine, Durham, N.C., and an investigator, Dermatology Consulting Services, High Point, N.C. A link to register for the event is available HERE. A live audio webcast and archived replay of the presentation will be available in the a href="https://www.globenewswire.com/Tracker?data=VacZZZmDOzNERMC-VPCVRXuxET1Z8lGnzMKYS5BpnzjJDAVuOUjA5TpB7HxlGiZNp9HToZwuNI8bTNrvUs9HCgpvEcvwUOH7nbXZBShGK_XoZOun3zG-a2VfI661u4sq" rel="nofollow" target="_blank">Investor Relations section of the Arcutis website. About Arcutis - Bioscience, applied to the skin. Investor Contact: |